From: MedicineNet Weekly News Digest
Title: Steroids May Be Overrated in Treatment of COPDCategory:
Health NewsCreated: 2/4/2010 2:10:00 PMLast Editorial Review:
2/5/2010
Respond to this topic on your own blog
Click and press Ctrl+C to copy and paste this discussion on your blog or site
Related Articles
Steroids May Be Overrated in COPD Exacerbation
It has been said in the past that regular treatment with inhaled
corticosteroids (better known as steroids) has been shown to reduce
the frequency of COPD exacerbation and improve health status in
patients with Stage III (severe) to Stage IV (very severe) COPD. A
new study published in the February, 2010 volume of Chest however,
seems to contradict this theory. After a thorough analysis of 11
studies (8,164 patients), it was revealed that the benefit from
inhaled corticosteroids (ICS) was modest at best, and only evident
in those patients whose FEV1 was less than 50%. The conclusion --
the benefit of ICS is somewhat overrated and should be reevaluated.
It will be interesting to find out if this news will affect COPD
treatment guidelines for the future. In the meantime, if you are
tak...
IV Steroids May Be Overkill in COPD Patients
Low-dose steroid pills seem to work as well as high doses of
injected steroids for patients hospitalized with severe chronic
obstructive pulmonary disease (COPD), researchers report. Yet, some
90 percent of these COPD patients are given the higher doses, which
is contrary to current prescribing guidelines, claims the study
appearing in the June 16 issue of the Journal of the American
Medical Association.
LABA Label Changes Apply to Asthma, Not COPD
Last week the FDA announced that, due to safety concerns, there
will be some changes in the way that long-acting beta agonists
(LABAs) are used in the treatment of asthma. The changes are based
on study analysis which showed LABAs were associated with an
increased risk of severe asthma exacerbation with related
hospitalizations and death in adults and children who used them for
the treatment of their asthma. It must be emphasized that while
LABAs are used to treat both asthma and COPD, the studies that the
FDA reviewed included patients using LABAs for the treatment of
asthma, NOT COPD. There is no evidence to conclude that people with
COPD who use LABAs are at any greater risk compared to people with
COPD who do not use LABAs. It is for this reason that the FDA does
not recommend any cha...
The Controversy of Anabolic Steroid Use in Sports
The use of androgenic anabolic steroids has been mired by
controversies over the years, where the many people who have been
using them have not been able to leave their usage except may be
after some tremendous health scare. The effect of boosting ones
muscle growth is what pushes many people towards the line of
androgenic anabolic steroids.
Spiriva HandiHaler Approved for the Reduction of COPD Exacerbations
How many of you use Spiriva HandiHaler for long-term maintenance
treatment of your COPD? Now, there's is one more reason to continue
to do so. Based on data from two clinical trials (UPLIFT and
Veteran's Affairs) and over 8,000 patients, Spiriva
HandiHaler (tiotropium oral powder for inhalation) has
been approved by the FDA for the reduction of exacerbations in
patients with COPD. While the UPLIFT trial failed to demonstrate as
it had hoped, that Spiriva Handihaler could slow lung
function decline, results demonstrated that it
sustained improved lung function over 4 years when compared to
placebo and reduced COPD exacerbations. If you are currently not
using Spiriva HandiHaler for COPD maintenance, now is the time you
might want to talk with your doctor about the possibility of
addin...